<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01608477</url>
  </required_header>
  <id_info>
    <org_study_id>BRIGHT</org_study_id>
    <nct_id>NCT01608477</nct_id>
  </id_info>
  <brief_title>Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation</brief_title>
  <acronym>BRIGHT</acronym>
  <official_title>Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Missouri, Kansas City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario À Coruña, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero, Universitaria Pisana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>US Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Louis Pradel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Nord Laennec, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Udine, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Puerta de Hierro University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Reina Sofia de Cordoba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Zürich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Papworth Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Freeman Hospital, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Toronto General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ottawa Heart Institute, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Paul's Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University Hospital, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St Luke's Hospital, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital of the University of Pennsylvania, USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ochsner Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Dante Pazzanese de Cardiologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto do Coração da Universidade de São Paulo, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St Vincent's Hospital, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Prince Charles Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Astellas Pharma Europe Ltd., UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Basel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the past decades, survival rates in heart transplantation recipients improved&#xD;
      significantly, due to advancements in regimens of immunosuppressives and surgical techniques,&#xD;
      but are still limited to the first 12 months post transplantation. Long-term survival remains&#xD;
      almost unchanged indicating the need to identify and improve relevant factors. Evidence in&#xD;
      other chronically-ill patient populations shows that the healthcare system (e.g. level of&#xD;
      chronic illness management (CIM)) and patient self-management (e.g. adherence) drive&#xD;
      improvements in outcomes.&#xD;
&#xD;
      The BRIGHT study is the first multi-centre, multi-continental study examining healthcare&#xD;
      system and heart transplant centres chronic illness management practice patterns and&#xD;
      potential correlates of immunosuppressive medication nonadherence.&#xD;
&#xD;
      The knowledge gained will inform clinicians, researchers and healthcare policy makers about&#xD;
      the level(s) interventions need to be implemented at to improve long-term outcomes for&#xD;
      transplant recipients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: After receiving a heart transplant (HTx) patients have to adhere to a number of&#xD;
      health behaviors (e.g., medication taking, and smoking cessation) in order to guarantee&#xD;
      optimal outcomes. Non-adherence to these health behaviors is associated with poor clinical&#xD;
      and economic outcomes. However, the prevalence of non-adherence to these health behaviors is&#xD;
      high among HTx recipients. Furthermore, differences in prevalences among countries and&#xD;
      continents are observed. The extent to which a HTx recipient is adherent is affected by a&#xD;
      variety of risk factors, namely 1) patient-related factors, 2) socioeconomic factors, 3)&#xD;
      therapy-related factors, 4) health-related factors and 5) healthcare system and team factors.&#xD;
      To-date, this last group of factors only received limited attention in understanding the&#xD;
      complex phenomena of adherence.&#xD;
&#xD;
      Aims: The aims of this study are:&#xD;
&#xD;
        1. To describe CIM practice patterns among centres, countries/continents in HTx.&#xD;
&#xD;
        2. To assess the prevalence and variability of nonadherence to treatment regimen, i.e.&#xD;
           medication taking, smoking cessation, diet keeping, alcohol consumption, physical&#xD;
           activity, sun protection and appointment keeping in HTx recipients among centres,&#xD;
           countries/continents.&#xD;
&#xD;
        3. To determine which multi-level factors are related to immunosuppressive medication&#xD;
           adherence at the different system levels&#xD;
&#xD;
        4. To benchmark the participating centres, countries and continents in relation to CIM&#xD;
           practice patterns and non-adherence to health behaviours&#xD;
&#xD;
      Methodology: The BRIGHT study is an international, multi-center, cross-sectional study. Data&#xD;
      were collected using interviews and questionnaires. HTx recipients, nurses working in the&#xD;
      post-transplantation care of HTx recipients and the medical directors of the HTx programs&#xD;
      were surveyed. The investigators recruited a convenience sample of 36 heart transplantation&#xD;
      centers (North America (n= 12), European (n= 19), Australia (n= 2) and South America (n= 3)).&#xD;
      Within participating centers, a random sample of patients who met the study eligibility&#xD;
      criteria was selected. Per center, a minimum of 20 and a maximum of 60 patients were&#xD;
      included. In total, 1677 heart transplant recipients were invited to participate in this&#xD;
      study. The questionnaires used in this study will be existing questionnaires (e.g. BAASIS&#xD;
      interview to assess adherence with medications, DASS to assess depression) as well as&#xD;
      questionnaires developed for this study.&#xD;
&#xD;
      During a regular follow-up visit, patients were invited by a staff person to participate in&#xD;
      this study. The staff first informed the patient about the study and, if the patient was&#xD;
      willing to participate, retrieved a signed informed consent. Participating in this study was&#xD;
      voluntary. Informed consent of the nurses and the medical director of the transplant center&#xD;
      were implied by completing the questionnaires. Participant names will be held in strict&#xD;
      confidence and will remain anonymous in research reports or publications.&#xD;
&#xD;
      The results of the benchmarking of the parameters assessed in this study will be reported by&#xD;
      figures and tables. Because of privacy, the HTx centers can only identify the parameters&#xD;
      specific to their center. All other information will be reported anonymously.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">March 2012</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Self-reported non-adherence to immunosuppressive medication</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about immunosuppressive medication taking during the prior 4 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported non-adherence to other medications (excl. immunosuppressive medications)</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about adherence to other medications (excl. immunosuppressive medications) during the prior 4 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to smoking cessation</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about current and past smoking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to dietary modifications</measure>
    <time_frame>once</time_frame>
    <description>Participants will be asked about adherence to dietary recommendations during the past year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported alcohol use</measure>
    <time_frame>Once</time_frame>
    <description>Participants are asked about alcohol intake during the past year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to physical activity</measure>
    <time_frame>Once</time_frame>
    <description>Participants are asked about their level of physical activity during the past week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to sun protection</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked about the routine use of sun protection measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported adherence to appointment keeping</measure>
    <time_frame>Once</time_frame>
    <description>Participants will be asked if they kept the last five appointments with the transplant team</description>
  </secondary_outcome>
  <enrollment type="Actual">1365</enrollment>
  <condition>Heart Transplantation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult heart transplant recipients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Heart transplant patients&#xD;
&#xD;
          -  18 years or older at time of inclusion&#xD;
&#xD;
          -  Transplanted and followed-up for routine care in a participating transplant center&#xD;
&#xD;
          -  First transplant&#xD;
&#xD;
          -  Single-organ transplant&#xD;
&#xD;
          -  Between 1 and 5 years post-transplant&#xD;
&#xD;
          -  Ability to read, understand and sign written informed consent (in Dutch, English,&#xD;
             French, German, Spanish, Italian, or Portuguese, depending on the languages spoken&#xD;
             within the country where the participating transplant center is located)&#xD;
&#xD;
          -  Provided written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Receiving professional support in medication taking&#xD;
&#xD;
          -  Involved in adherence-intervention research or drug trials during the past 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabina M De Geest, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Basel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals of Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Berben L, Russell C, Engberg S, Dobbels F, De Geest S. Development, content validity and inter-rater reliability testing of the Chronic Illness Management Implementation - Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation: An instrument to assess the level of chronic illness management implemented in solid organ transplant programmes. International Journal of Care Coordination. 2014;17(1-2):59-71.</citation>
  </reference>
  <reference>
    <citation>Berben L, Denhaerynck K, Dobbels F, Engberg S, Vanhaecke J, Crespo-Leiro MG, Russell CL, De Geest S; BRIGHT study consortium. Building research initiative group: chronic illness management and adherence in transplantation (BRIGHT) study: study protocol. J Adv Nurs. 2015 Mar;71(3):642-54. doi: 10.1111/jan.12519. Epub 2014 Sep 26.</citation>
    <PMID>25257974</PMID>
  </reference>
  <results_reference>
    <citation>Cajita MI, Denhaerynck K, Dobbels F, Berben L, Russell CL, Davidson PM, De Geest S; BRIGHT study team. Health literacy in heart transplantation: Prevalence, correlates and associations with health behaviors-Findings from the international BRIGHT study. J Heart Lung Transplant. 2017 Mar;36(3):272-279. doi: 10.1016/j.healun.2016.08.024. Epub 2016 Sep 13. Erratum in: J Heart Lung Transplant. 2017 Jun;36(6):700.</citation>
    <PMID>27773449</PMID>
  </results_reference>
  <results_reference>
    <citation>Cajita MI, Baumgartner E, Berben L, Denhaerynck K, Helmy R, Schönfeld S, Berger G, Vetter C, Dobbels F, Russell CL, De Geest S; BRIGHT Study Team. Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - Findings from the International BRIGHT Study. Heart Lung. 2017 Sep - Oct;46(5):351-356. doi: 10.1016/j.hrtlng.2017.05.006. Epub 2017 Jun 16.</citation>
    <PMID>28624338</PMID>
  </results_reference>
  <results_reference>
    <citation>Senft Y, Kirsch M, Denhaerynck K, Dobbels F, Helmy R, Russell CL, Berben L, De Geest S; BRIGHT study team. Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. Eur J Cardiovasc Nurs. 2018 Apr 1;17(4):356-367. doi: 10.1177/1474515117747577. Epub 2017 Dec 1.</citation>
    <PMID>29231747</PMID>
  </results_reference>
  <results_reference>
    <citation>Denhaerynck K, Berben L, Dobbels F, Russell CL, Crespo-Leiro MG, Poncelet AJ, De Geest S; BRIGHT study team. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study. Am J Transplant. 2018 Jun;18(6):1447-1460. doi: 10.1111/ajt.14611. Epub 2018 Jan 16.</citation>
    <PMID>29205855</PMID>
  </results_reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>May 18, 2012</study_first_submitted>
  <study_first_submitted_qc>May 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2012</study_first_posted>
  <last_update_submitted>January 24, 2019</last_update_submitted>
  <last_update_submitted_qc>January 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Basel</investigator_affiliation>
    <investigator_full_name>Sabina De Geest</investigator_full_name>
    <investigator_title>PhD, RN, FAAN, FRCN</investigator_title>
  </responsible_party>
  <keyword>Heart transplantation</keyword>
  <keyword>Medication adherence</keyword>
  <keyword>Behavior system factor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://dx.doi.org/10.1111/jan.12519</doc_url>
      <doc_comment>Building research initiative group: chronic illness management and adherence in transplantation (BRIGHT) study: study protocol</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

